The last time it was announced that Mary Beckerle would be leaving the Huntsman Cancer Institute, there was uproar. But this ...

It's hard out there for the token not-quite-Republican on "The View." It's basically like being the drummer in Spinal Tap: You're going to go one way or another, and it won't be pretty. Of course, the ...

Recent News: On July 7, Dow announced it will shut down three European plants, which may result in up to $790 million worth ...

The rating agency cited reduced earnings, elevated debt leverage, and limited operational and financial flexibility as key factors behind the downgrade. Moody’s also assigned a Ba1 Corporate Family ...

Christopher Nolan's The Odyssey has an ensemble of a star-studded cast, including Matt Damon, Robert Pattinson, Anne Hathaway ...

But I also know that dangers lurk in the Daintree Rainforest. Saltwater crocodiles are known to patrol the Daintree ...

Wall Street’s major indices ended the trading week on a strong note, clocking in robust gains as investors cheered better-than-expected non-farm payrolls last month while digesting more ...

Chairman and CEO Peter Huntsman said the investment reflects their commitment to innovating semiconductor-grade products and strengthening global supply chains in response to AI-driven chip demand.

Huntsman Cancer Institute CEO Mary Beckerle speaks at the groundbreaking for a new cancer center on Tuesday, April 8, 2025, in Vineyard.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.